Drug of choice in PSVT is-
The core concept here is the management of PSVT. The primary goal is to terminate the arrhythmia quickly. I remember that adenosine is the first-line treatment. Why adenosine? Because it acts on the AV node, which is the key part of the heart's electrical system. Adenosine is a purinergic agonist that activates A1 receptors, leading to hyperpolarization of the AV nodal cells. This slows conduction through the AV node, which can interrupt the re-entry circuit responsible for PSVT.
Now, looking at the options, the correct answer is adenosine. Let's think about the other drugs. Verapamil is a calcium channel blocker and might be used if adenosine isn't available, but it's not the first choice. Beta-blockers like metoprolol could also be used in certain cases, but again, adenosine is preferred. Digoxin is more for other types of arrhythmias, like atrial fibrillation, and isn't effective for PSVT.
Wait, what about other antiarrhythmics? Flecainide is a class Ic drug, but it's more for ventricular arrhythmias or in cases where there's a structural heart issue. So, definitely not first-line here. Amiodarone is broad-spectrum but again, not first-line for PSVT.
Clinical pearl: Remember the mnemonic "AV nodal blocks are blocks for AV nodal re-entry tachycardia." So adenosine, verapamil, and beta-blockers all slow AV nodal conduction. But adenosine is the fastest acting and has the shortest half-life, making it the drug of choice. Also, note that adenosine can cause transient asystole, so it's given as a rapid IV push.
**Core Concept**
PSVT (Paroxysmal Supraventricular Tachycardia) is a rapid heart rhythm due to abnormal electrical circuits involving the AV node. The drug of choice must rapidly slow AV nodal conduction to terminate the arrhythmia. Adenosine is central to this mechanism.
**Why the Correct Answer is Right**
Adenosine is a purinergic agonist that activates A1 receptors in the AV node, causing potassium efflux and hyperpolarization. This slows AV nodal conduction, interrupting the re-entry circuit in PSVT. Its ultra-short half-life (10 seconds) allows rapid termination with minimal systemic effects. It is administered as a 6 mg IV bolus, repeated as 12 mg if needed.
**Why Each Wrong Option is Incorrect**
**Option A:** Verapamil (calcium channel blocker) may be used if adenosine fails but is not first-line due to slower onset and risk of hypotension.
**Option B:** Beta-blockers (e.g., metoprolol) are alternatives in hemodynamically stable patients but require higher doses and longer administration.
**Option C:** Digoxin is ineffective for acute PSVT termination and